CS Tumor Size CS Extension CS Tumor Size/Ext Eval CS Lymph Nodes CS Lymph Nodes Eval Reg LN Pos Reg LN Exam CS Mets at DX CS Mets Eval
|
|
- Kerry Francis
- 6 years ago
- Views:
Transcription
1 Base of Tongue, Lingual Tonsil C01.9, C02.4 C01.9 Base of tongue, NOS C02.4 Lingual tonsil Note: AJCC inludes base of tongue (C01.9) with oropharynx (C10._). CS Tumor Size CS Extension CS Tumor Size/Ext Eval CS Lymph Nodes CS Lymph Nodes Eval Reg LN Pos Reg LN Exam CS Mets at DX CS Mets Eval CS Site-Speifi Fator 1 Size of Lymph Nodes CS Site-Speifi Fator 2 OBSOLETE - Extraapsular Extension, Lymph Nodes for Head and Nek CS Site-Speifi Fator 3 Levels I-III, Lymph Nodes for Head and Nek CS Site-Speifi Fator 4 Levels IV-V and Retropharyngeal Lymph Nodes for Head and Nek CS Site-Speifi Fator 5 Levels VI-VII and Faial Lymph Nodes for Head and Nek CS Site-Speifi Fator 6 Parapharyngeal, Parotid, and Suboipital/Retroauriular Lymph Nodes, Lymph Nodes for Head and Nek CS Site-Speifi Fator 7 Upper and Lower Cervial Node Levels CS Site-Speifi Fator 8 Extraapsular Extension Clinially, Lymph Nodes for Head and Nek CS Site-Speifi Fator 9 Extraapsular Extension Pathologially, Lymph Nodes for Head and Nek CS Site-Speifi Fator 10 HPV (Human Papilloma Virus) Status CS Site-Speifi Fator 11 CS Site-Speifi Fator 12 CS Site-Speifi Fator 13 CS Site-Speifi Fator 14 CS Site-Speifi Fator 15 CS Site-Speifi Fator 16 CS Site-Speifi Fator 17 CS Site-Speifi Fator 18 CS Site-Speifi Fator 19 CS Site-Speifi Fator 20 CS Site-Speifi Fator 21 CS Site-Speifi Fator 22 CS Site-Speifi Fator 23 CS Site-Speifi Fator 24 CS Site-Speifi Fator 25 The following tables are available at the ollaborative staging website: Histology Inlusion Table AJCC 7th ed. Histology Exlusion Table AJCC 6th ed. AJCC TNM 7 Stage AJCC TNM 6 Stage Summary Stage Extension Size Table AJCC 7 Extension Size Table AJCC 6 Lymph Nodes Size Table Base of Tongue, Lingual Tonsil CS Tumor Size (Revised: 07/29/2009) Note 1: the speifi tumor size as stated in the medial reord. Use ode 992 or 994 if the physiian's statement about T value is the ONLY information available about the size of the tumor. (Refer to the CS Extension table for instrutions on oding extension.) 000 No mass/tumor found 29 April 2010 Part II - Tongue and Gum - 1 Version
2 millimeters (ode exat size in millimeters) millimeters or larger 990 Mirosopi fous or foi only, no size of fous given 991 Desribed as "less than 1 m" 992 Desribed as "less than 2 m," or "greater than 1 m," or "between 1 m and 2 m" Stated as T1 with no other information on size 993 Desribed as "less than 3 m," or "greater than 2 m," or "between 2 m and 3 m" 994 Desribed as "less than 4 m," or "greater than 3 m," or "between 3 m and 4 m" Stated as T2 with no other information on size 995 Desribed as "less than 5 m," or "greater than 4 m," or "between 4 m and 5 m" 996 Desribed as "greater than 5m" 999 Unknown; size not stated Base of Tongue, Lingual Tonsil CS Extension (Revised: 01/24/2010) Note 1: Use ode 300 for loalized tumor ONLY if no information is available to assign odes 100, 200, 400, 405, or 410. Note 2: Use ode 405, 410, 650, 775, 810, or 815 if the physiian's assignment of T ategory is the ONLY information available about the extent of the tumor. TNM 7 TNM 6 SS77 SS In situ; noninvasive; intraepithelial Tis Tis IS IS 100 Invasive tumor on one side onfined to posterior 1/3 of tongue: Lamina propria Submuosa ^ * L L 200 Musulature, intrinsi or NOS ^ * L L 300 Loalized, NOS Midline tumor ^ * L L 400 Tumor rosses midline ^ * L L 405 Stated as T1 with no other information on extension ^ * L L 410 Stated as T2 with no other information on extension ^ * L L 500 Anterior 2/3 of tongue for base of tongue Base of tongue for lingual tonsil Floor of mouth Lower gingiva ^ * RE RE 29 April 2010 Part II - Tongue and Gum - 2 Version
3 TNM 7 TNM 6 SS77 SS Sublingual gland ^ * RE RE 600 OBSOLETE DATA RETAINED V0200 ERROR * RE RE Epiglottis, lingual (pharyngeal) surfae Glossoepiglotti fold Glossopharyngeal fold Lateral pharyngeal wall Pharyngoepiglotti fold Tonsillar pillars and fossae Tonsils Valleula Note: Epiglottis, lingual surfae assigned to T3 in AJCC 7, see ode Glossoepiglotti fold Glossopharyngeal fold Lateral pharyngeal wall Pharyngoepiglotti fold Tonsillar pillars and fossae Tonsils Valleula ^ * RE RE 620 Soft palate, inferior surfae or NOS inluding uvula ^ * D RE 640 Epiglottis, lingual surfae T3 * RE RE T3 * D RE (Epiglottis, lingual surfae + Soft palate) 650 Stated as T3 with no other information on extension T3 * RE RE 710 Mandible for lingual tonsil T4a T4a RE D T4a T4a D D (Mandible + Soft palate) 720 Mandible for base of tongue T4a T4a D D 740 Medial pterygoid musle Hard palate 750 Musulature of tongue, extrinsi: Genioglossus Geniohyoid Hyoglossus Mylohyoid Palatoglossus Styloglossus T4a T4a D D T4a T4a D D 760 Hypopharynx T4a T4a D D 770 Larynx T4a T4a D D 29 April 2010 Part II - Tongue and Gum - 3 Version
4 TNM 7 TNM 6 SS77 SS Stated as T4a with no other information on extension T4a T4a RE RE 780 Skin T4b T4b D D 790 Lateral nasopharynx Lateral pterygoid musle Pterygoid plates 800 OBSOLETE DATA RETAINED V0200 T4b T4b D D ERROR T4b D D Contiguous extension to: Base of skull Carotid artery Hypopharynx Lateral nasopharynx Lateral pterygoid musle Pterygoid plates Uvula Note: Uvula ombined with soft palate in CSV2, see ode 620 Note: Hypopharynx moved to orret mapping in CSV2, see ode 760 Note: Lateral nasopharynx, lateral pterygoid musle, pterygoid plates moved to 790 in CSV2 805 Further ontiguous extension inluding: Skull base Carotid artery T4b T4b D D 810 Stated as T4b with no other information on extension T4b T4b D D 815 Stated as T4 NOS with no other information on extension 820 OBSOLETE DATA CONVERTED V0200 Combined with other ontiguous extension, see ode 805) Further ontiguous extension T4NOS T4NOS RE RE ERROR ERROR ERROR ERROR 950 No evidene of primary tumor T0 T0 U U 999 Unknown extension Primary tumor annot be assessed TX TX U U ^For Extension odes ONLY, the T ategory for AJCC 7th Edition staging is assigned based on the value of CS Tumor Size, as shown in the Extension Size Table AJCC 7 for this site. *For Extension odes ONLY, the T ategory for AJCC 6th Edition staging is assigned based on the value of CS Tumor Size, as shown in the Extension Size Table AJCC 6 for this site. 29 April 2010 Part II - Tongue and Gum - 4 Version
5 Base of Tongue, Lingual Tonsil CS Tumor Size/Ext Eval (Revised: 08/10/2009) Staging Basis 0 Does not meet riteria for AJCC pathologi staging: No surgial resetion done. Evaluation based on physial examination, imaging examination, or other non-invasive linial evidene. No autopsy evidene used. 1 Does not meet riteria for AJCC pathologi staging: No surgial resetion done. Evaluation based on endosopi examination, diagnosti biopsy, inluding fine needle aspiration biopsy, or other invasive tehniques, inluding surgial observation without biopsy. No autopsy evidene used. 2 Meets riteria for AJCC pathologi staging: p No surgial resetion done, but evidene derived from autopsy (tumor was suspeted or diagnosed prior to autopsy) 3 Either riteria meets AJCC pathologi staging: p Surgial resetion performed WITHOUT pre-surgial systemi treatment or radiation OR surgial resetion performed, unknown if pre-surgial systemi treatment or radiation performed AND Evaluation based on evidene aquired before treatment, supplemented or modified by the additional evidene aquired during and from surgery, partiularly from pathologi examination of the reseted speimen. No surgial resetion done. Evaluation based on positive biopsy of highest T lassifiation. 5 Does not meet riteria for AJCC y-pathologi (yp) staging: Surgial resetion performed AFTER neoadjuvant therapy and tumor size/extension based on linial evidene, unless the pathologi evidene at surgery (AFTER neoadjuvant) is more extensive (see ode 6). 6 Meets riteria for AJCC y-pathologi (yp) staging: yp Surgial resetion performed AFTER neoadjuvant therapy AND tumor size/extension based on pathologi evidene, beause pathologi evidene at surgery is more extensive than linial evidene before treatment. 8 Meets riteria for autopsy (a) staging: a Evidene from autopsy only (tumor was unsuspeted or undiagnosed prior to autopsy) 9 Unknown if surgial resetion done Not assessed; annot be assessed Unknown if assessed 29 April 2010 Part II - Tongue and Gum - 5 Version
6 Base of Tongue, Lingual Tonsil CS Lymph Nodes (Revised: 08/25/2009) Note 1: For head and nek shemas, this field inludes all lymph nodes defined as Levels I-VII and Other by AJCC. The omplete definitions are provided in the General Instrutions. Note 2: For head and nek shemas, additional information about lymph nodes (size of involved nodes, extraapsular extension, levels involved, and loation of involved nodes above or below the lower border of the rioid artilage) is oded in Site-Speifi Fators 1, 3-9. Note 3: If laterality of lymph nodes is not speified, assume nodes are ipsilateral. Midline nodes are onsidered ipsilateral. Note 4: For head and nek aners, if lymph nodes are desribed only as "supralaviular", try to determine if they are in Level IV (deep to the sternoleidomastoid musle, in the lower jugular hain) or Level V (in the posterior triangle, inferior to the transverse ervial artery) and ode appropriately. If the speifi level annot be determined, onsider them as Level V nodes. Note 5: The desription of lymph nodes has been standardized aross the head and nek shemas. All lymph node levels and groups listed here are onsidered regional nodes for AJCC staging. Summary Stage 1977 and Summary Stage 2000 divide these nodes into regional and distant groups. Note 6: Level IA submental nodes moved from ode 100 in CSV1 to ode 110. TNM 7 TNM 6 SS77 SS None; no regional lymph node involvement N0 N0 NONE NONE 100 Single positive ipsilateral regional node: Level I node Level IB - Submandibular (submaxillary), sublingual Level II node Upper jugular Jugulodigastri (subdigastri) Upper deep ervial Level III node Middle jugular Middle deep ervial Level IV node - Lower jugular Virhow node Cervial, NOS Deep ervial, NOS Internal jugular, NOS Mandibular, NOS Regional lymph node, NOS 110 Single postitive ipsilateral regional node: Level I node Level IA - Submental ^ * RN RN ^ * D RN 29 April 2010 Part II - Tongue and Gum - 6 Version
7 TNM 7 TNM 6 SS77 SS Single positive ipsilateral regional node: Level V node - Posterior triangle group Posterior ervial Level VA - Spinal aessory Level VB - Transverse ervial, supralaviular Level VI node - Anterior ompartment group Laterotraheal Paralaryngeal Paratraheal - above suprasternal noth Perithyroidal Prerioid (Delphian) Prelaryngeal Pretraheal - above suprasternal noth Reurrent laryngeal Level VII node - Super mediastinal group (for other mediastinal nodes see CS Mets at DX) Esophageal groove Paratraheal - below suprasternal noth Other groups: Faial: Buinator (bual) Mandibular Nasolabial Parotid: Infra-auriular Intraparotid Periparotid Preauriular Parapharyngeal Retropharyngeal Suboipital ^ * D D 180 Stated as N1, no other information N1 N1 RN RN 190 Stated as N2a, no other information N2a N2a RN RN 200 Multiple positive ipsilateral nodes listed in ode 100 ^ * RN RN 210 Multiple positive ipsilateral nodes, any listed in ode 110 (WITH or WITHOUT nodes listed in ode 100) 220 Multiple positive ipsilateral nodes, any listed in ode 120 (WITH or WITHOUT nodes listed in ode 100 or 110) ^ * D RN ^ * D D 290 Stated as N2b, no other information N2b N2b RN RN 300 Regional lymph nodes listed in ode 100: Positive ipsilateral node(s), not stated if single or multiple ^ * RN RN 29 April 2010 Part II - Tongue and Gum - 7 Version
8 TNM 7 TNM 6 SS77 SS Regional lymph nodes listed in ode 110: Positive ipsilateral node(s), not stated if single or multiple 320 Regional lymph nodes listed in ode 120: Positive ipsilateral node(s), not stated if single or multiple 400 Regional lymph nodes listed in ode 100: Positive bilateral or ontralateral nodes 410 Regional lymph nodes, any listed in ode 110: Positive bilateral or ontralateral nodes (WITH or WITHOUT nodes listed in ode 100) 420 Regional lymph nodes, any listed in ode 120: Positive bilateral or ontralateral nodes (WITH or WITHOUT nodes listed in ode 100 or 110) ^ * D RN ^ * D D ^ * RN RN ^ * D RN ^ * D D 490 Stated as N2, no other information N2 N2 RN RN 500 Regional lymph nodes listed in ode 100: Positive node(s), not stated if ipsilateral, or bilateral, or ontralateral, AND not stated if single or multiple 510 Regional lymph nodes listed in ode 110: Positive node(s), not stated if ipsilateral, or bilateral, or ontralateral, AND not stated if single or multiple 520 Regional lymph nodes listed in ode 120: Positive node(s), not stated if ipsilateral, or bilateral, or ontralateral, AND not stated if single or multiple ^ * RN RN ^ * D RN ^ * D D 600 Stated as N2, NOS N2NOS N2NOS RN RN 700 Stated as N3, no other information N3 N3 RN RN 800 Lymph nodes, NOS ^ * RN RN 999 Unknown; not stated Regional lymph nodes annot be assessed NX NX U U ^ For odes , , , , and 800 ONLY, the N ategory for AJCC 7th Edition staging is assigned based on the value of Site-Speifi Fator 1, Size of Lymph Nodes, using the extra table, Lymph Nodes Size Table, for this site. * For odes , , , , and 800 ONLY, the N ategory for AJCC 6th Edition staging is assigned based on the value of Site-Speifi Fator 1, Size of Lymph Nodes, using the extra table, Lymph Nodes Size Table, for this site. 29 April 2010 Part II - Tongue and Gum - 8 Version
9 Base of Tongue, Lingual Tonsil CS Lymph Nodes Eval (Revised: 10/26/2009) Note 1: This field is used primarily to derive the staging basis for the N ategory in the TNM system. It reords how the ode for the item "CS Lymph Nodes" was determined based on the diagnosti methods employed and their intent. Note 2: In the 7th edition of the AJCC manual, the linial and pathologi lassifiation rules for the N ategory were hanged to reflet urrent medial pratie. The N is designated as linial or pathologi based on the intent (workup versus treatment) mathing with the assessment of the T lassifiation. When the intent is workup, the staging basis is linial, and when the intent is treatment, the staging basis is pathologi. A. Mirosopi assessment inluding biopsy of regional nodes or sentinel nodes if being performed as part of the workup to hoose the treatment plan, is therefore part of the linial staging. When it is part of the workup, the T ategory is linial, and there has not been a resetion of the primary site adequate for pathologi T lassifiation (whih would be part of the treatment). B. Mirosopi assessment of regional nodes if being performed as part of the treatment is therefore part of the pathologi staging. When it is part of the treatment, the T ategory is pathologi, and there has been a resetion of the primary site adequate for pathologi T lassifiation (all part of the treatment). Note 3: Mirosopi assessment of the highest N ategory is always pathologi (ode 3). Note 4: If lymph node dissetion is not performed after neoadjuvant therapy, use ode 0 or 1. Note 5: Only odes 5 and 6 are used if the node assessment is performed after neoadjuvant therapy. Staging Basis 0 Does not meet riteria for AJCC pathologi staging: No regional lymph nodes removed for examination. Evidene based on physial examination, imaging examination, or other non-invasive linial evidene. No autopsy evidene used. 1 Does not meet riteria for AJCC pathologi staging based on at least one of the following riteria: No regional lymph nodes removed for examination. Evidene based on endosopi examination, or other invasive tehniques inluding surgial observation, without biopsy. No autopsy evidene used. OR Fine needle aspiration, inisional ore needle biopsy, or exisional biopsy of regional lymph nodes or sentinel nodes as part of the diagnosti workup, WITHOUT removal of the primary site adequate for pathologi T lassifiation (treatment). 2 Meets riteria for AJCC pathologi staging: p No regional lymph nodes removed for examination, but evidene derived from autopsy (tumor was suspeted or diagnosed prior to autopsy). 3 Meets riteria for AJCC pathologi staging based on at least one of the following riteria: p Any mirosopi assessment of regional nodes (inluding FNA, inisional ore needle bx, exisional bx, sentinel node bx or node resetion), WITH removal of the primary site adequate for pathologi T lassifiation (treatment) or biopsy assessment of the highest T ategory. OR Any mirosopi assessment of a regional node in the highest N ategory, regardless of the T ategory information. 29 April 2010 Part II - Tongue and Gum - 9 Version
10 Staging Basis 5 Does not meet riteria for AJCC y-pathologi (yp) staging: Regional lymph nodes removed for examination AFTER neoadjuvant therapy AND lymph node evaluation based on linial evidene, unless the pathologi evidene at surgery (AFTER neoadjuvant) is more extensive (see ode 6). 6 Meets riteria for AJCC y-pathologi (yp) staging: yp Regional lymph nodes removed for examination AFTER neoadjuvant therapy AND lymph node evaluation based on pathologi evidene, beause the pathologi evidene at surgery is more extensive than linial evidene before treatment. 8 Meets riteria for AJCC autopsy (a) staging: a Evidene from autopsy; tumor was unsuspeted or undiagnosed prior to autopsy. 9 Unknown if lymph nodes removed for examination Not assessed; annot be assessed Unknown if assessed Base of Tongue, Lingual Tonsil Reg LN Pos (Revised: 03/30/2009) Note: Reord this field even if there has been preoperative treatment. 00 All nodes examined negative nodes positive (ode exat number of nodes positive) or more nodes positive 95 Positive aspiration or ore biopsy of lymph node(s) 97 Positive nodes - number unspeified 98 No nodes examined 99 Unknown if nodes are positive; not appliable Base of Tongue, Lingual Tonsil Reg LN Exam (Revised: 03/02/2009) 00 No nodes examined nodes examined (ode exat number of regional lymph nodes examined) or more nodes examined 29 April 2010 Part II - Tongue and Gum - 10 Version
11 95 No regional nodes removed, but aspiration or ore biopsy of regional nodes performed 96 Regional lymph node removal doumented as sampling and number of nodes unknown/not stated 97 Regional lymph node removal doumented as dissetion and number of nodes unknown/not stated 98 Regional lymph nodes surgially removed but number of lymph nodes unknown/not stated and not doumented as sampling or dissetion; nodes examined, but number unknown 99 Unknown if nodes were examined; not appliable or negative Base of Tongue, Lingual Tonsil CS Mets at DX (Revised: 07/23/2009) Note: Supralaviular and transverse ervial lymph nodes are oded in CS Lymph Nodes beause they are ategorized as N rather than M in AJCC TNM. TNM 7 TNM 6 SS77 SS No; none M0 M0 NONE NONE 10 Distant lymph node(s) Mediastinal Distant lymph node(s), NOS 40 Distant metastases exept distant lymph node(s)(ode 10) Carinomatosis 50 (10) + (40) Distant lymph node(s) plus other distant metastases 60 Distant metastasis, NOS Stated as M1, NOS 99 Unknown if distant metastasis Distant metastasis annot be assessed M1 M1 D D M1 M1 D D M1 M1 D D M1 M1 D D M0 MX U U Base of Tongue, Lingual Tonsil CS Mets Eval (Revised: 08/10/2009) Note: This item reflets the validity of the lassifiation of the item CS Mets at DX only aording to the diagnosti methods employed. Staging Basis 0 Does not meet riteria for AJCC pathologi staging of distant metastasis: Evaluation of distant metastasis based on physial examination, imaging examination, and/or other non-invasive linial evidene. No pathologi examination of metastati tissue performed or pathologi examination was negative. 29 April 2010 Part II - Tongue and Gum - 11 Version
12 Staging Basis 1 Does not meet riteria for AJCC pathologi staging of distant metastasis: Evaluation of distant metastasis based on endosopi examination or other invasive tehnique, inluding surgial observation without biopsy. No pathologi examination of metastati tissue performed or pathologi examination was negative. 2 Meets riteria for AJCC pathologi staging of distant metastasis: p No pathologi examination of metastati speimen done prior to death, but positive metastati evidene derived from autopsy (tumor was suspeted or diagnosed prior to autopsy). 3 Meets riteria for AJCC pathologi staging of distant metastasis: p Speimen from metastati site mirosopially positive WITHOUT pre-surgial systemi treatment or radiation OR speimen from metastati site mirosopially positive, unknown if pre-surgial systemi treatment or radiation performed OR speimen from metastati site mirosopially positive prior to neoadjuvant treatment. 5 Does not meet riteria for AJCC y-pathologi (yp) staging of distant metastasis: Speimen from metastati site mirosopially positive WITH pre-surgial systemi treatment or radiation, BUT metastasis based on linial evidene. 6 Meets riteria for AJCC y-pathologi (yp) staging of distant metastasis: Speimen from metastati site mirosopially positive WITH pre-surgial systemi treatment or radiation, BUT metastasis based on pathologi evidene. 8 Meets riteria for AJCC autopsy (a) staging of distant metastasis: yp a Evidene from autopsy based on examination of positive metastati tissue AND tumor was unsuspeted or undiagnosed prior to autopsy. 9 Not assessed; annot be assessed Unknown if assessed Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 1 Size of Lymph Nodes (Revised: 12/01/2009) Note: the largest diameter, whether measured linially or pathologially, of any involved regional lymph node(s). Do not ode the size of any nodes oded in CS Mets at DX. 000 No involved regional nodes millimeters (ode exat size in millimeters) millimeters or larger 29 April 2010 Part II - Tongue and Gum - 12 Version
13 OBSOLETE DATA CONVERTED V0200 See ode millimeters 989 OBSOLETE DATA CONVERTED V0200 See ode millimeters or larger 990 Mirosopi fous or foi only, no size of fous given 991 Desribed as "less than 1m" 992 Desribed as "less than 2m" or "greater than 1m" or "between 1m and 2m" 993 Desribed as "less than 3m" or "greater than 2m" or "between 2m and 3m" 994 Desribed as "less than 4m" or "greater than 3m" or "between 3m and 4m" 995 Desribed as "less than 5m" or "greater than 4m" or "between 4m and 5m" 996 Desribed as "less than 6m" or "greater than 5m" or "between 5m and 6m" 997 Desribed as "more than 6m" 999 Regional lymph node(s) involved, size not stated Unknown if regional lymph node(s) involved Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 2 OBSOLETE - Extraapsular Extension, Lymph Nodes for Head and Nek (Revised: 12/30/2009) Note 1: This CS Site-Speifi Fator is obsolete beginning with CS Version 2 (odes and notes). Old data are retained, but new ases are not oded with this Fator. Use ode 988 for this field. Note 2: the status of extraapsular extension whether assessed linially or pathologially of any involved regional lymph node(s) oded in the CS Lymph Nodes field. Do not ode extraapsular extension in any nodes oded in CS Mets at DX in this field. Note 3: A statement of the presene or absene of extraasular extension in a pathology report takes priority over linial assessment. However, if the pathology report ontains no statement about extraapsular extension, either positive or negative, the linial assessment should be oded. If nodes are involved but there is neither a linial assessment of extranodal extension nor a statement about it in the pathology report, use ode 999. Note 4: Aording to AJCC (page 24), "Imaging studies showing amorphous speulated margins of involved nodes or involvement of internodal fat resulting in loss of normal oval-to-round nodal shape strongly suggest extraapsular (extranodal) tumor spread; however, pathologi examination is neessary for doumentation of the extent of suh disease." Note 5: CS Site-Speifi Fator 2 is obsolete beginning with CS Version 2 (odes and notes). Old data are retained, but new ases are not oded with this Fator. Use ode 988 for this field. 000 OBSOLETE DATA RETAINED V0200 No extraapsular extension 29 April 2010 Part II - Tongue and Gum - 13 Version
14 001 OBSOLETE DATA RETAINED V0200 Extraapsular extension linially, not assessed pathologially Nodes desribed as "fixed", not assessed pathologially 005 OBSOLETE DATA RETAINED V0200 Extraapsular extension present pathologially 888 OBSOLETE DATA CONVERTED V0200 See ode 987 Not appliable; no lymph node involvement 987 OBSOLETE DATA CONVERTED AND RETAINED V0200 Data onverted from ode 888 Not appliable; no lymph node involvement 988 Not appliable: Information not olleted for this ase 999 OBSOLETE DATA RETAINED V0200 Unknown if regional lymph node(s) involved, not stated Regional lymph nodes annot be assessed Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 3 Levels I-III, Lymph Nodes for Head and Nek (Revised: 03/30/2009) Note: Site-Speifi Fators 3-6 are used to ode the presene or absene of lymph node involvement in eah of 7 different levels and other groups defined by AJCC. The definitions of the levels are the same for all appliable head and nek sites. One digit is used to represent lymph nodes of a single level, with the three digits of Site-Speifi Fator 3 representing lymph nodes of, respetively, Levels I-III; the digits of Site-Speifi Fator 4 representing lymph nodes of Levels IV and V and the retropharyngeal nodes; the digits of Site-Speifi Fator 5 representing lymph nodes of Levels VI and VII and the faial nodes; and the digits of Site-Speifi Fator 6 representing the remaining Other groups as defined by AJCC. In eah digit, a ode 1 means Yes, the nodes are involved. 000 No lymph node involvement in Levels I, II, or III 100 Level I lymph node(s) involved 010 Level II lymph node(s) involved 001 Level III lymph node(s) involved 110 Level I and II lymph nodes involved 101 Level I and III lymph nodes involved 011 Level II and III lymph nodes involved 111 Level I, II and III lymph nodes involved 29 April 2010 Part II - Tongue and Gum - 14 Version
15 999 Unknown if regional lymph node(s) involved, not stated Regional lymph nodes annot be assessed Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 4 Levels IV-V and Retropharyngeal Lymph Nodes for Head and Nek (Revised: 03/30/2009) Note: Site-Speifi Fators 3-6 are used to ode the presene or absene of lymph node involvement in eah of 7 different levels and other groups defined by AJCC. The definitions of the levels are the same for all appliable head and nek sites. One digit is used to represent lymph nodes of a single level, with the three digits of Site-Speifi Fator 3 representing lymph nodes of, respetively, Levels I-III; the digits of Site-Speifi Fator 4 representing lymph nodes of Levels IV and V and the retropharyngeal nodes; the digits of Site-Speifi Fator 5 representing lymph nodes of Levels VI and VII and the faial nodes; and the digits of Site-Speifi Fator 6 representing the remaining Other groups as defined by AJCC. In eah digit, a ode 1 means Yes, the nodes are involved. 000 No lymph node involvement in Levels IV or V or retropharyngeal 100 Level IV lymph node(s) involved 010 Level V lymph node(s) involved 001 Retropharyngeal nodes involved 110 Level IV and V lymph nodes involved 101 Level IV and retropharyngeal nodes involved 011 Level V and retropharyngeal nodes involved 111 Level IV and V and retropharyngeal lymph nodes involved 999 Unknown if regional lymph node(s) involved, not stated Regional lymph nodes annot be assessed Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 5 Levels VI-VII and Faial Lymph Nodes for Head and Nek (Revised: 03/30/2009) Note 1: Site-Speifi Fators 3-6 are used to ode the presene or absene of lymph node involvement in eah of 7 different levels and other groups defined by AJCC. The definitions of the levels are the same for all appliable head and nek sites. One digit is used to represent lymph nodes of a single level, with the three digits of Site-Speifi Fator 3 representing lymph nodes of, respetively, Levels I-III; the digits of Site-Speifi Fator 4 representing lymph nodes of Levels IV and V and the retropharyngeal nodes; the digits of Site-Speifi Fator 5 representing lymph nodes of Levels VI and VII and the faial nodes; and the digits of Site-Speifi Fator 6 representing the remaining Other groups as defined by AJCC. In eah digit, a ode 1 means Yes, the nodes are involved. Note 2: Faial nodes inluding buinator, mandibular, and nasolabial lymph nodes. 000 No lymph node involvement in Levels VI or VII or faial nodes 29 April 2010 Part II - Tongue and Gum - 15 Version
16 100 Level VI lymph node(s) involved 010 Level VII lymph node(s) involved 001 Faial lymph node(s) involved 110 Level VI and VII lymph nodes involved 101 Level VI and faial nodes involved 011 Level VII and faial nodes involved 111 Level VI and VII and faial lymph nodes involved 999 Unknown if regional lymph node(s) involved, not stated Regional lymph nodes annot be assessed Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 6 Parapharyngeal, Parotid, and Suboipital/Retroauriular Lymph Nodes, Lymph Nodes for Head and Nek (Revised: 08/25/2009) Note: Site-Speifi Fators 3-6 are used to ode the presene or absene of lymph node involvement in eah of 7 different levels and other groups defined by AJCC. The definitions of the levels are the same for all appliable head and nek sites. One digit is used to represent lymph nodes of a single level, with the three digits of Site-Speifi Fator 3 representing lymph nodes of, respetively, Levels I-III; the digits of Site-Speifi Fator 4 representing lymph nodes of Levels IV and V and the retropharyngeal nodes; the digits of Site-Speifi Fator 5 representing lymph nodes of Levels VI and VII and the faial nodes; and the digits of Site-Speifi Fator 6 representing the remaining Other groups as defined by AJCC. In eah digit, a ode 1 means Yes, the nodes are involved. 000 No involvement of any group: Parapharyngeal lymph nodes Parotid (preauriular, periparotid, and/or intraparotid) lymph nodes Suboipital/retroauriular lymph nodes 100 Parapharyngeal lymph node(s) involved 010 Parotid (preauriular, periparotid, and/or intraparotid) lymph node(s) involved 001 Suboipital/retroauriular lymph node(s) involved 110 Involvement of two groups: Parapharyngeal lymph nodes Parotid (preauriular, periparotid, and/or intraparotid) lymph nodes 101 Involvement of two groups: Parapharyngeal lymph nodes Suboipital/retroauriular lymph nodes 011 Involvement of two groups: Parotid (preauriular, periparotid, and/or intraparotid) lymph nodes Suboipital lymph nodes 29 April 2010 Part II - Tongue and Gum - 16 Version
17 111 Involvement of three groups: Parapharyngeal lymph nodes Parotid (preauriular, periparotid, and/or intraparotid) lymph nodes, Suboipital/retroauriular lymph nodes 999 Unknown if regional lymph node(s) involved, not stated Regional lymph nodes annot be assessed Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 7 Upper and Lower Cervial Node Levels (Revised: 03/30/2009) Note 1: AJCC requires that nodes be designated as involving upper or lower levels within the nek. The boundary between upper and lower levels is the lower border of the rioid artilage. Note 2: Nodes in Levels I, II, and III are upper level nodes. Nodes in Level IV and VII are lower level nodes. Level VA nodes are upper level nodes, and Level VB are lower level nodes. Level VI nodes span both upper and lower levels. Nodes inluded in "Other groups" (Faial, Parotid, Parapharyngeal, Retropharyngeal, Retroauriular, and Suboipital) are all upper level nodes. Note 3: the loation of nodal involvement in relation to the lower border of the rioid artilage of all involved nodes, whether assessed linially or pathologially, as stated by a physiian. Note 4: If there is no physiian statement of upper and/or lower level nodal involvement, assign levels I, II, III, and VA nodes to upper level. Assign level IV, VB, and VII to lower level. If Level V (A and B not speified) and/or Level VI nodes are involved with no further information about loation, use ode 040. Note 5: A desription of "mid nek" requires larifiation with the physiian. 040, unknown level, if "mid nek" is the only information available. 000 No lymph nodes involved 010 Upper level lymph nodes involved (all involved nodes above the lower border of the rioid artilage) 020 Lower level lymph nodes involved (all involved nodes below the lower border of the rioid artilage) 030 Upper and lower level lymph nodes involved (all involved nodes both above and below the lower border of the rioid artilage) 040 Unknown level lymph nodes involved (unable to determine if involved nodes above or below the lower border of the rioid artilage) 988 Not appliable: Information not olleted for this ase 999 Unknown if regional lymph node(s) involved, not stated 29 April 2010 Part II - Tongue and Gum - 17 Version
18 Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 8 Extraapsular Extension Clinially, Lymph Nodes for Head and Nek (Revised: 10/16/2009) Note 1: the status of extraapsular extension aessed linially for any involved regional lymph node(s) oded in the CS Lymph Nodes field. Do not ode extraapsular extensio in any nodes oded in CS Mets at DX in this field. Note 2: If nodes are involved linially, and doumentation of physial examination or imaging is available without a statement of extraapsular extension, use ode 010. Note 3: If the only doumentation is a referene to linially involved nodes with no referene to extraapsular extension, use ode 030. Note 4: If there is no information about linial assessment of nodes, use ode 999. Note 5: Clinial assessment an be by physial examination or imaging. Aording to AJCC, "ECS an be diagnosed linially by a matted mass of nodes adherent to overlying skin, adjaent soft tissue, or linial evidene of ranial nerve tissue. Radiologi signs of ECS inlude amorphous, spiulated margins of a metastati node and stranding of the perinodal soft tissue in previously untreated patients." 000 No lymph nodes involved linially 010 Nodes involved linially, no extraapsular extension linially 020 Nodes involved linially, extraapsular extension linially (nodes desribed as fixed or matted) 030 Nodes involved linially, unknown if extraapsular extension 988 Not appliable: Information not olleted for this ase 997 Clinial examination of lymph nodes performed, unknown results 998 No linial examination of lymph nodes 999 Unknown if regional lymph node(s) involved linially, not stated Regional lymph nodes annot be aessed Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 9 Extraapsular Extension Pathologially, Lymph Nodes for Head and Nek (Revised: 08/25/2009) Note 1: the status of extraapsular extension assessed pathologially of any involved regional lymph node(s) oded in the CS Lymph Nodes field. Do not ode extraapsular extension in any nodes oded in CS Mets at DX in this field. Note 2: If nodes are involved pathologially but there is no statement of extranodal extension in the pathology report, use ode 010. Note 3: "mirosopi" or "marosropi" extranodal extension as stated in the final diagnosis. If not stated in the final diagnosis, ode "mirosopi" if extranodal extension is desribed only in the mirosopi setion of the pathology report and "marosopi" if extranodal extension is desribed in the gross setion of the pathology report. Note 4: "Marosopi" extension takes priority over "mirosopi" extension. Note 5: Use ode 040 if pathologi extraapsular extension is desribed with no further information and the pathology report is not available for review. Note 6: Use ode 050 if nodes involved pathologially with no further information about extraapsular extension. 000 No lymph nodes involved pathologially 29 April 2010 Part II - Tongue and Gum - 18 Version
19 010 Nodes involved pathologially, no extraapsular extension pathologially 020 Nodes involved pathologially, MICROSCOPIC extraapsular extension pathologially 030 Nodes involved pathologially, MACROSCOPIC extraapsular extension pathologially 040 Nodes involved pathologially, extraapsular extension pathologially, unknown if mirosopi or marosopi 050 Nodes involved pathologially, unknown if extraapsular extension 988 Not appliable: Information not olleted for this ase 997 Pathologi examination of lymph nodes performed, results not available 998 No pathologi examination of lymph nodes 999 Unknown if regional lymph node(s) involved pathologially, not stated Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 10 HPV (Human Papilloma Virus) Status (Revised: 10/12/2009) Note 1: There is evidene that human papilloma virus (HPV) plays a role in the pathogenesis of some aners. Note 2: Reord the results of any HPV testing performed on pathologi speimens from the primary tumor or a metastati site, inluding regional nodes. HPV testing may be performed for prognosti purposes; testing may also be performed on metastati sites to aid in the determination of the primary site. Note 3: The highest risk HPV types are types 16 and 18. Other high risk types are 31, 33, 35, 36, 45, 51, 52, 56, 58, 59, 68, 26, 53, 66, 67, 69, 70, 73, 82, 85 Low risk types are 6, 11, 32, 34, 40, 42, 44, 54, 61, 62, 64, 71, 72, 74, 81, 83, 84, 87, 89. The HPV vaine is designed to protet against types 16 and 18 (assoiated with ervial aner) and types 6 and 11 (assoiated with genital warts). Note 4: High risk may be abbreviated "hrhpv" or "HR-HPV". Note 5: Some tests for HPV, suh as a hybrid apture test, only report negative or positive for high risk HPV without identifying types; use odes 025 and 050, respetively to report those test results. 000 HPV test negative; not positive for any HPV types Negative, NOS 010 LOW RISK positive (all positive type(s) are low risk) 020 HIGH RISK positive, speified type(s) other than types 16 or 18, WITH or WITHOUT positive results for low risk type(s) 030 HIGH RISK positive for HPV 16 WITHOUT positive results for HPV 18 or positivity of HPV 18 unknown, WITH or WITHOUT positive results for other high-risk types, WITH or WITHOUT positive results for low risk type(s) 040 HIGH RISK positive for HPV 18 WITHOUT positive results for HPV 16 or positivity of HPV 16 unknown, WITH or WITHOUT positive results for other high-risk types, WITH or WITHOUT positive results for low risk type(s) 29 April 2010 Part II - Tongue and Gum - 19 Version
20 050 HIGH RISK positive for HPV 16 AND HPV 18, WITH or WITHOUT positive results for other high-risk types, WITH or WITHOUT positive results for low risk type(s) 060 HIGH RISK positive, NOS, type(s) not speified 070 Positive, NOS, risk and type(s) not stated 988 Not appliable: Information not olleted for this ase 997 Test ordered, results not in hart 998 Test not done (test was not ordered and was not performed), inluding no pathologi speimen available for HPV testing 999 Unknown or no information Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 11 (Revised: 06/30/2008) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 12 (Revised: 06/30/2008) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 13 (Revised: 06/30/2008) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 14 (Revised: 06/30/2008) 29 April 2010 Part II - Tongue and Gum - 20 Version
21 Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 15 (Revised: 06/30/2008) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 16 (Revised: 02/23/2009) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 17 (Revised: 02/23/2009) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 18 (Revised: 02/23/2009) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 19 (Revised: 02/23/2009) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 20 (Revised: 02/23/2009) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 21 (Revised: 02/23/2009) 29 April 2010 Part II - Tongue and Gum - 21 Version
22 Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 22 (Revised: 02/23/2009) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 23 (Revised: 02/23/2009) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 24 (Revised: 02/23/2009) Base of Tongue, Lingual Tonsil CS Site-Speifi Fator 25 (Revised: 02/23/2009) 29 April 2010 Part II - Tongue and Gum - 22 Version
23 Malignant Melanoma of Base of Tongue, Lingual Tonsil C01.9, C02.4 (M ) C01.9 Base of tongue, NOS C02.4 Lingual tonsil CS Tumor Size CS Extension CS Tumor Size/Ext Eval CS Lymph Nodes CS Lymph Nodes Eval Reg LN Pos Reg LN Exam CS Mets at DX CS Mets Eval CS Site-Speifi Fator 1 Size of Lymph Nodes CS Site-Speifi Fator 2 OBSOLETE - Extraapsular Extension, Lymph Nodes for Head and Nek CS Site-Speifi Fator 3 Levels I-III, Lymph Nodes for Head and Nek CS Site-Speifi Fator 4 Levels IV-V and Retropharyngeal Lymph Nodes for Head and Nek CS Site-Speifi Fator 5 Levels VI-VII and Faial Lymph Nodes for Head and Nek CS Site-Speifi Fator 6 Parapharyngeal, Parotid, and Suboipital/Retroauriular Lymph Nodes, Lymph Nodes for Head and Nek CS Site-Speifi Fator 7 Upper and Lower Cervial Node Levels CS Site-Speifi Fator 8 Extraapsular Extension Clinially, Lymph Nodes for Head and Nek CS Site-Speifi Fator 9 Extraapsular Extension Pathologially, Lymph Nodes for Head and Nek CS Site-Speifi Fator 10 HPV (Human Papilloma Virus) Status CS Site-Speifi Fator 11 Measured Thikness (Depth) CS Site-Speifi Fator 12 CS Site-Speifi Fator 13 CS Site-Speifi Fator 14 CS Site-Speifi Fator 15 CS Site-Speifi Fator 16 CS Site-Speifi Fator 17 CS Site-Speifi Fator 18 CS Site-Speifi Fator 19 CS Site-Speifi Fator 20 CS Site-Speifi Fator 21 CS Site-Speifi Fator 22 CS Site-Speifi Fator 23 CS Site-Speifi Fator 24 CS Site-Speifi Fator 25 The following tables are available at the ollaborative staging website: Histology Inlusion Table AJCC 7th ed. Histology Exlusion Table AJCC 6th ed. AJCC TNM 7 Stage AJCC TNM 6 Stage Summary Stage Malignant Melanoma of Base of Tongue, Lingual Tonsil CS Tumor Size (Revised: 02/03/2010) 000 No mass/tumor found millimeters (ode exat size in millimeters) 29 April 2010 Part II - Tongue and Gum - 23 Version
24 millimeters or larger 990 Mirosopi fous or foi only and no size of fous given 991 Desribed as "less than 1 m" 992 Desribed as "less than 2 m," or "greater than 1 m," or "between 1 m and 2 m" 993 Desribed as "less than 3 m," or "greater than 2 m," or "between 2 m and 3 m" 994 Desribed as "less than 4 m," or "greater than 3 m," or "between 3 m and 4 m" 995 Desribed as "less than 5 m," or "greater than 4 m," or "between 4 m and 5 m" 999 Unknown; size not stated Malignant Melanoma of Base of Tongue, Lingual Tonsil CS Extension (Revised: 01/04/2010) Note 1: AJCC does not inlude a Tis or TX for melanoma of muosa of head and nek sites. Extension odes of 000 and 999 will be mapped to NA and AJCC stage group will be derived as NA. Note 2: AJCC does not inlude a T1 or T2 ategory for muosal melanoma of head and nek sites. Note 3: Use ode 305 for loalized tumor ONLY if no information is available to assign ode 105, 310, 405, or 510. Note 4: Use ode 510, 785, 810, or 815 if the physiian's assignment of T ategory is the ONLY information available about the extent of the tumor. TNM 7 TNM 6 SS77 SS In situ; noninvasive; intraepithelial NA NA IS IS 100 OBSOLETE DATA RETAINED V0200 ERROR NA L L Invasive tumor on one side onfined to posterior 1/3 of tongue: Lamina propria Submuosa 105 Tumor onfined to muosa on one side of posterior one-third of tongue 200 OBSOLETE DATA RETAINED V0200 T3 NA L L ERROR NA L L Musulature, intrinsi or NOS 29 April 2010 Part II - Tongue and Gum - 24 Version
25 TNM 7 TNM 6 SS77 SS OBSOLETE DATA RETAINED V0200 ERROR NA L L Loalized, NOS Midline tumor 305 Loalized, NOS T3 NA L L 310 Midline tumor onfined to muosa T3 NA L L 400 OBSOLETE DATA RETAINED V0200 ERROR NA L L Tumor rosses midline 405 Tumor rosses midline, onfined to muosa T3 NA L L 460 Extension via muosa to: Anterior 2/3 of tongue for base of tongue Base of tongue for lingual tonsil Floor of mouth Lower gingiva 470 Extension via muosa to: Epiglottis, lingual (pharyngeal) surfae Glossoepiglotti fold Glossopharyngeal fold Lateral pharyngeal wall Pharyngoepiglotti fold Tonsillar pillars and fossae Tonsils Valleula 480 Extension via muosa to: Soft palate inluding uvula 490 Extension via muosa to: Larynx Hypopharynx T3 NA RE RE T3 NA RE RE T3 NA D RE T3 NA D D 495 Extension via muosa to hard palate T3 NA D D 500 OBSOLETE DATA RETAINED V0200 ERROR NA RE RE Anterior 2/3 of tongue for base of tongue Base of tongue for lingual tonsil Floor of mouth Lower gingiva 510 Stated as T3 with no other information on extension T3 NA L L 520 Deep soft tissue or musulature of any struture listed in ode 105, 310, or 405 Soft tissue NOS T4a NA L L 29 April 2010 Part II - Tongue and Gum - 25 Version
26 TNM 7 TNM 6 SS77 SS (460 or 470) T4a NA RE RE (Involvement of deep soft tissue or musulature of any struture listed in ode 105, 310, or Muosal involvement of a ny struture in ode 460 or 470 ) T4a NA D RE (Involvement of deep soft tissue or musulature of any struture listed in ode 105, 310, or Muosal involvement of soft palate) (490 or 510) T4a NA D D (Involvement of deep soft tissue or musulature of any struture listed in ode 105, 310, or Muosal involvement of any struture in ode 490 or 510) 530 Sublingual gland T4a NA RE RE 550 Involvement of deep soft tissue or musulature of any struture in ode OBSOLETE DATA RETAINED V0200 T4a NA RE RE ERROR NA RE RE Epiglottis, lingual (pharyngeal) surfae Glossoepiglotti fold Glossopharyngeal fold Lateral pharyngeal wall Pharyngoepiglotti fold Tonsillar pillars and fossae Tonsils Valleula 29 April 2010 Part II - Tongue and Gum - 26 Version
27 TNM 7 TNM 6 SS77 SS (470 or 530) T4a NA D RE (Involvement of sublingual gland or deep soft tissue or musulature of any struture in ode Muosal involvement of soft palate) 612 (470 or 530) + (490 or 510) T4a NA D D (Involvement of sublingual gland or deep soft tissue or musulature of any struture in ode Muosal involvement of any struture in ode 490 or 510) 620 Deep soft tissue or musulature of Soft palate, inferior surfae or NOS inluding uvula T4a NA D RE 710 Mandible for lingual tonsil T4a NA RE D (480 or 620) T4a NA D D (Mandible + Any involvement of soft palate) 720 Mandible for base of tongue T4a NA D D 740 OBSOLETE DATA RETAINED V0200 Medial pterygoid musle Hard palate 750 Musulature, extrinsi of tongue: Genioglossus Geniohyoid Hyoglossus Mylohyoid Palatoglossus Styloglossus 770 Deep soft tissue or musulature of: Larynx Hypopharynx ERROR NA D D T4a NA D D T4a NA D D 29 April 2010 Part II - Tongue and Gum - 27 Version
28 TNM 7 TNM 6 SS77 SS Lateral nasopharynx Pterygoid musle Pterygoid plates Bone exluding base of skull, mandible Palatine bone Bone NOS Cartilage NOS T4a NA D D 780 Overlying skin T4a NA D D 785 Stated as T4a with no other information on extension T4a NA L L 790 Contiguous extension to: Carotid artery (enased) Prevertebral spae Mediastinal strutures 800 OBSOLETE DATA RETAINED V0200 Contiguous extension to: Base of skull Carotid artery Hypopharynx Lateral nasopharynx Lateral pterygoid musle Pterygoid plates Uvula 801 Further ontiguous extension inluding: Brain Dura Skull base Lower ranial nerves (IX, X, XI, XII) Mastiator spae T4b NA D D ERROR NA D D T4b NA D D 810 Stated as T4b with no other information on extension T4b NA D D 815 Stated as T4 NOS with no other information on extension 820 OBSOLETE DATA RETAINED V0200 Further ontiguous extension 950 OBSOLETE DATA RETAINED V0200 No evidene of primary tumor 999 Unknown extension Primary tumor annot be assessed T4NOS NA L L ERROR NA D D ERROR NA U U NA NA U U 29 April 2010 Part II - Tongue and Gum - 28 Version
29 Malignant Melanoma of Base of Tongue, Lingual Tonsil CS Tumor Size/Ext Eval (Revised: 11/13/2009) Staging Basis 7 Staging Basis 6 0 Does not meet riteria for AJCC pathologi staging: No surgial resetion done. Evaluation based on physial examination, imaging examination, or other non-invasive linial evidene. No autopsy evidene used. 1 Does not meet riteria for AJCC pathologi staging: No surgial resetion done. Evaluation based on endosopi examination, diagnosti biopsy, inluding fine needle aspiration biopsy, or other invasive tehniques, inluding surgial observation without biopsy. No autopsy evidene used. 2 Meets riteria for AJCC pathologi staging: p No surgial resetion done, but evidene derived from autopsy (tumor was suspeted or diagnosed prior to autopsy) 3 Either riteria meets AJCC pathologi staging: p Surgial resetion performed WITHOUT pre-surgial systemi treatment or radiation OR surgial resetion performed, unknown if pre-surgial systemi treatment or radiation performed AND Evaluation based on evidene aquired before treatment, supplemented or modified by the additional evidene aquired during and from surgery, partiularly from pathologi examination of the reseted speimen. No surgial resetion done. Evaluation based on positive biopsy of highest T lassifiation. 5 Does not meet riteria for AJCC y-pathologi (yp) staging: Surgial resetion performed AFTER neoadjuvant therapy and tumor size/extension based on linial evidene, unless the pathologi evidene at surgery (AFTER neoadjuvant) is more extensive (see ode 6). 6 Meets riteria for AJCC y-pathologi (yp) staging: yp Surgial resetion performed AFTER neoadjuvant therapy AND tumor size/extension based on pathologi evidene, beause pathologi evidene at surgery is more extensive than linial evidene before treatment. 8 Meets riteria for autopsy (a) staging: a Evidene from autopsy only (tumor was unsuspeted or undiagnosed prior to autopsy) 29 April 2010 Part II - Tongue and Gum - 29 Version
CS Tumor Size CS Extension CS Tumor Size/Ext Eval CS Lymph Nodes CS Lymph Nodes Eval Reg LN Pos Reg LN Exam CS Mets at DX CS Mets Eval
Floor of Mouth C04.0-C04.1, C04.8-C04.9 C04.0 Anterior floor of mouth C04.1 Lateral floor of mouth C04.8 Overlapping lesion of floor of mouth C04.9 Floor of mouth, NOS CS Tumor Size CS Extension CS Tumor
More informationCS Tumor Size CS Extension CS Tumor Size/Ext Eval CS Lymph Nodes CS Lymph Nodes Eval Reg LN Pos Reg LN Exam CS Mets at DX CS Mets Eval
Lip, Upper Lip (Vermilion or Labial Muosa) C00.0, C00.3 C00.0 External upper lip C00.3 Muosa of upper lip Note: AJCC inludes labial muosa (C00.3) with bual muosa (C06.0) CS Tumor Size CS Extension CS Tumor
More informationKidneyParenchyma. Kidney (Renal Parenchyma)
http://web2.fas.org/stage/kidneyparenhyma/shema.html for TNM 7 - Revised 01/21/2010 Kidney (Renal Parenhyma) C64.9 C64.9 Kidney, NOS (Renal parenhyma) Note: Laterality must be oded for this site. CS Tumor
More informationC15.0-C15.5, C15.8-C15.9
C15.0-C15.5, C15.8-C15.9 C15.0 Cervial esophagus C15.1 Thorai esophagus C15.2 Abdominal esophagus C15.3 Upper third of esophagus C15.4 Middle third of esophagus C15.5 Lower third of esophagus C15.8 Overlapping
More informationC15.0-C15.5, C15.8-C15.9
Esophagus C15.0-C15.5, C15.8-C15.9 C15.0 Cervial esophagus C15.1 Thorai esophagus C15.2 Abdominal esophagus C15.3 Upper third of esophagus C15.4 Middle third of esophagus C15.5 Lower third of esophagus
More informationStomach CS Tumor Size (Revised: 06/30/2008)
C16.1-C16.6, C16.8-C16.9 C16.1 Fundus of stomah C16.2 Body of stomah C16.3 Gastri antrum C16.4 Pylorus C16.5 Lesser urvature of stomah, NOS C16.6 Greater urvature of stomah, NOS C16.8 Overlapping lesion
More informationNasal Cavity CS Tumor Size (Revised: 02/03/2010)
Nasal Cavity C30.0 C30.0 Nasal cavity (excludes nose, NOS C76.0) Note: Laterality must be coded for this site, except subsites Nasal cartilage and Nasal septum, for which laterality is coded 0. CS Tumor
More informationCollaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]
CS Tumor Size Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ] Note: the specific tumor size as documented in the medical record. If the ONLY information regarding tumor size is the physician's
More informationQ&A. Fabulous Prizes. Collecting Cancer Data: Pharynx 12/6/12. NAACCR Webinar Series Collecting Cancer Data Pharynx
Collecting Cancer Data Pharynx NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationAJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY-
TX: primary tumor cannot be assessed T0: no evidence of primary tumor Tis: carcinoma in situ. T1: tumor is 2 cm or smaller AJCC Staging of Head & Neck Cancer (7 th edition, 2010) -LIP & ORAL CAVITY- T2:
More information14. Mucosal Melanoma of the Head and Neck
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationCollaborative Stage for TNM 7 - Revised 07/14/2009 [ Schema ]
MelanomaSkin CS Tumor Size Collaborative Stage for TNM 7 - Revised 07/14/2009 [ Schema ] Code 000 No mass/tumor found Description 001-988 001-988 millimeters (code exact size in millimeters) 989 989 millimeters
More informationCollaborative Staging Manual and Coding Instructions Part II: Primary Site Schema
C44.0-C44.9, C51.0-C51.2, C51.8-C51.9, C60.0-C60.2, C60.8-C60.9, C63.2 (M-8720-8790) C44.0 Skin of lip, NOS C44.1 Eyelid C44.2 External ear C44.3 Skin of ear and unspecified parts of face C44.4 Skin of
More information10. HPV-Mediated (p16+) Oropharyngeal Cancer
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationEVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013
EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 Head and Neck Coding and Staging Head and Neck Coding and Staging Anatomy & Primary Site Sequencing and MPH
More informationNAACCR Webinar Series
NAACCR 2009-2010 Webinar Series Collecting Cancer Data: Lip & Oral Cavity 8/5/2010 Questions Please use the Q&A panel to submit your questions Send questions to All Panelist 2 Fabulous Prizes! NAACCR 2009/2010
More informationThis form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationNAACCR Webinar Series 1
Collecting Cancer Data: Lip and Oral 2013 2014 NAACCR Webinar Series October 3, 2013 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants
More informationCollaborative Stage for TNM 7 - Revised 06/30/2008 [ Schema ]
Collaborative Stage for TNM 7 - Revised 06/30/2008 [ Schema ] CS Tumor Size 000 No mass/tumor found 001-988 001-988 millimeters (code exact size in millimeters) 989 989 millimeters or larger 990 Microscopic
More information6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationThis form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More information(loco-regional disease)
(loco-regional disease) (oral cavity) (circumvillae papillae) (subsite) A (upper & lower lips) B (buccal membrane) C (mouth floor) D (upper & lower gingiva) E (hard palate) F (tongue -- anterior 2/3 rds
More informationExercise 15: CSv2 Data Item Coding Instructions ANSWERS
Exercise 15: CSv2 Data Item Coding Instructions ANSWERS CS Tumor Size Tumor size is the diameter of the tumor, not the depth or thickness of the tumor. Chest x-ray shows 3.5 cm mass; the pathology report
More informationHead & Neck Clinical Sub Group. Network Agreed Imaging Guidelines for UAT and Thyroid Cancer. Measure Nos: 11-1C-105i & 11-1C-106i
Greater Manchester, Lancashire & South Cumbria Strategic Clinical Network & Senate Head & Neck Clinical Sub Group Network Agreed Imaging Guidelines for UAT and Thyroid Cancer Measure Nos: 11-1C-105i &
More informationThyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES
AJC 7/14/06 1:19 PM Page 67 Thyroid C73.9 Thyroid gland SUMMARY OF CHANGES Tumor staging (T) has been revised and the categories redefined. T4 is now divided into T4a and T4b. Nodal staging (N) has been
More informationHead and Neck Tumours
Head and Neck Tumours Introductory Notes The following sites are included: Lip, oral cavity Pharynx: oropharynx, nasopharynx, hypopharynx Larynx: supraglottis, glottis, subglottis Nasal cavity and paranasal
More informationCase Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 1 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of
More informationAJCC Cancer Staging 8 th edition. Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx
AJCC Cancer Staging 8 th edition Lip and Oral Cavity Oropharynx (p16 -) and Hypopharynx Larynx AJCC 7 th edition Lip and Oral cavity Pharynx Larynx KEY CHANGES Skin of head and neck (Vermilion of the lip)
More informationCS Tumor Size CS Extension CS Tumor Size/Ext Eval CS Lymph Nodes CS Lymph Nodes Eval Reg LN Pos Reg LN Exam CS Mets at DX CS Mets Eval
C70.0, C71.0-C71.9 C70.0 Cerebral meninges C71.0 Cerebrum C71.1 Frontal lobe C71.2 Temporal lobe C71.3 Parietal lobe C71.4 Occipital lobe C71.5 Ventricle, NOS C71.6 Cerebellum, NOS C71.7 Brain stem C71.8
More informationCase Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of alcohol.
More informationNAACCR Webinar Series 1. Instructors Q&A 10/6/2011. Collecting Cancer Data: Larynx Including Mucosal Melanoma of Larynx.
NAACCR 2011 2012 Webinar Series Collecting Cancer Data: Larynx Instructors Shannon Vann, CTR Jim Hofferkamp, CTR 2 Q&A Please submit all questions concerning webinar content through the Q&A panel. 3 NAACCR
More informationOral cavity : consist of two parts: the oral vestibule and the oral cavity proper. Oral vestibule : is slit like space between.
Oral cavity Oral cavity : consist of two parts: the oral vestibule and the oral cavity proper Oral vestibule : is slit like space between the teeth, buccal gingiva, lips, and cheeks 1 Oral cavity Oral
More informationAnatomy of Oral Cavity DR. MAAN AL-ABBASI
Anatomy of Oral Cavity DR. MAAN AL-ABBASI By the end of this lecture you should be able to: 1. Differentiate different parts of the oral cavity 2. Describe the blood and nerve supply of mucosa and muscles
More informationBasic Anatomy and Physiology of the Lips and Oral Cavity. Dr. Faghih
Basic Anatomy and Physiology of the Lips and Oral Cavity Dr. Faghih It is divided into seven specific subsites : 1. Lips 2. dentoalveolar ridges 3. oral tongue 4. retromolar trigone 5. floor of mouth 6.
More informationNAACCR Hospital Registry Webinar Series
NAACCR Hospital Registry Webinar Series Shannon Vann, CTR Jim Hofferkamp, CTR Webinar Series 1 Abstracting Thyroid Cancer Incidence & Image source: Thyroid ABC Health and Well Being Webinar Series 2 Anatomy
More informationHead & Neck Case # 1
DISCHARGE SUMMARY Head & Neck Case # 1 Date of Admission: 10/30/2010 Date of Discharge: 11/02/2010 Present Medical History: The patient is a 33-year-old lady with a history of right superior alveolar ridge
More informationHead & Neck Contouring
Head & Neck Contouring Presented by James Wheeler, MD Center for Cancer Care Goshen, IN 46526 September 12, 2014 Special Thanks to: Spencer Boulter, Director of Operations (AAMD) Adam Moore, RT(T), CMD
More informationLYMPHATIC DRAINAGE IN THE HEAD & NECK
LYMPHATIC DRAINAGE IN THE HEAD & NECK Like other parts of the body, the head and neck contains lymph nodes (commonly called glands). Which form part of the overall Lymphatic Drainage system of the body.
More information6 th Reprint Handbook Pages AJCC 7 th Edition
6 th Reprint Handbook Pages AJCC 7 th Edition AJCC 7 th Edition Errata for 6 th Reprint Table 1 Handbook No Significant Staging Clarifications for 6 th Reprint AJCC 7 th Edition Errata for 6 th Reprint
More informationThe following images were all acquired using a CTI Biograph
Positron Emission Tomography/ Computed Tomography Imaging of Head and Neck Tumors: An Atlas Michael M. Graham, MD, PhD, and Yusuf Menda, MD Department of Radiology, University of Iowa, Iowa City, IA. Address
More informationFINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma
Case Scenario 1 HNP: A 70 year old white male presents with dysphagia. The patient is a current smoker, current user of alcohol and is HPV positive. A CT of the Neck showed mass in the left pyriform sinus.
More informationEvaluation and Treatment of Dysphagia in the Head and Neck Cancer Patient
Evaluation and Treatment of Dysphagia in the Head and Neck Cancer Patient Linda Stachowiak MS/CCCSLP BCS-S Speech Pathology Oncology Specialist UFHealth Cancer Center at Orlando Health Orlando Florida
More informationQUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX
QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX MP/H Quiz 1. A patient presented with a prior history of squamous cell carcinoma of the base of the tongue. The malignancy was originally diagnosed
More informationCompartmentalization of the larynx Sites and subsites Supraglottis Glottis subglottis Spaces Pre-epiglottic epiglottic space Para-glottic space
Stroboscopy Rounds February 8, 2008 C. Matt Stewart, M.D.,Ph.D. Compartmentalization of the larynx Sites and subsites Supraglottis Glottis subglottis Spaces Pre-epiglottic epiglottic space Para-glottic
More informationLecture 07. Lymphatic's of Head & Neck. By: Dr Farooq Amanullah Khan PMC
Lecture 07 Lymphatic's of Head & Neck By: Dr Farooq Amanullah Khan PMC Dated: 28.11.2017 Lymphatic Vessels Of the 800 lymph nodes in the human body, 300 are in the Head & neck region. The lymphatic vessels
More informationOral cancer: Prognosis & Treatment. Dr. Hani Al Sheikh Radhi
Oral cancer: Prognosis & Treatment Dr. Hani Al Sheikh Radhi Prognostic factors in Oral caner TNM staging T stage N stage M stage Site Histological Factors Vascular & Perineural Invasion Surgical Margins
More informationEsophagus Stomach 4/2/15
Collecting Cancer Data: Larynx & Thyroid 2014-2015 NAACCR Webinar Series May 7, 2015 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants
More informationCERVICAL LYMPH NODES
CERVICAL LYMPH NODES (ANATOMY & EXAMINATION) Hemant (DTCD 1 st YEAR) 1. Lymphatic Tissues: A Type of connective tissue that contains large numbers of lymphocytes. 2. Lymphatic Vessels: Are Tubes that assist
More informationAJCC update Disclosures. AJCC TNM staging system. Objectives:
Disclosures AJCC update 2018 Remy Lobo, MD remylobo@med.umich.edu remy.lobo@hsc.utah.edu No relevant disclosures Information is based on the 8 th AJCC manual Amin MB, Edge SB, Greene FL et al, eds. AJCC
More informationSubdivided into Vestibule & Oral cavity proper
Extends from the lips to the oropharyngeal isthmus The oropharyngeal isthmus: Is the junction of mouth and pharynx. Is bounded: Above by the soft palate and the palatoglossal folds Below by the dorsum
More informationQUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX
QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX MP/H Quiz 1. A patient presented with a prior history of squamous cell carcinoma of the base of the tongue. The malignancy was originally diagnosed
More informationSITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR
SITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR Anus: Anal Canal; Anus, NOS; Other Parts of Rectum C21.0-C21.2, C21.8 C21.0 Anus, NOS (excludes skin of anus and perianal skin C44.5) C21.1 Anal canal C21.2
More informationARTICLE. Imaging of tongue carcinoma
Cancer Imaging (2006) 6, 186 193 DOI: 10.1102/1470-7330.2006.0029 CI ARTICLE Imaging of tongue carcinoma Cheng K Ong and Vincent F H Chong Department of Diagnostic Radiology, National University Hospital,
More informationNAACCR Webinar Series 11/2/2017
COLLECTING CANCER DATA: LARYNX 2017 2018 NAACCR WEBINAR SERIES Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationThe Neck the lower margin of the mandible above the suprasternal notch and the upper border of the clavicle
The Neck is the region of the body that lies between the lower margin of the mandible above and the suprasternal notch and the upper border of the clavicle below Nerves of the neck Cervical Plexus Is formed
More informationL ARYNX S TAGING F ORM
CLI N I CA L Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery TX T0 Tis a b L ARYNX S TAGING F ORM LATERALITY: TUMOR SIZE: left
More informationFACULTY OF MEDICINE SIRIRAJ HOSPITAL
Neck Dissection Pornchai O-charoenrat MD, PhD Division of Head, Neck and Breast Surgery Department of Surgery FACULTY OF MEDICINE SIRIRAJ HOSPITAL Introduction Status of the cervical lymph nodes is the
More informationCase Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma
Case Scenario 1 History A 52 year old male with a 20 pack year smoking history presented with about a 6 month history of persistent hoarseness. The patient had a squamous cell carcinoma of the lip removed
More informationThyroid and Adrenal Gland
Thyroid and Adrenal Gland NAACCR 2011 2012 Webinar Series 12/1/11 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationAnatomy of Head of Neck Cancer
Anatomy of Head of Neck Cancer J. Robert Newman, MD The ENT Center of Central GA H&N Cancer Overview Most categories of cancer are represented in the H&N Squamous cell carcinoma most common mucosal cancer
More information47. Melanoma of the Skin
1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting
More informationANTERIOR CERVICAL TRIANGLE (Fig. 2.1 )
2 Neck Anatomy ANTERIOR CERVICAL TRIANGLE (Fig. 2.1 ) The boundaries are: Lateral: sternocleidomastoid muscle Superior: inferior border of the mandible Medial: anterior midline of the neck This large triangle
More informationCase Scenario #1 Larynx
Case Scenario #1 Larynx 56 year old white female who presented with a 2 month history of hoarseness treated with antibiotics, but with no improvement. In the last 3 weeks, she has had a 15 lb weight loss,
More informationPrevertebral Region, Pharynx and Soft Palate
Unit 20: Prevertebral Region, Pharynx and Soft Palate Dissection Instructions: Step1 Step 2 Step 1: Insert your fingers posterior to the sternocleidomastoid muscle, vagus nerve, internal jugular vein,
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More information2. Guidelines for Reporting Head and Neck Tumours
39 40 2. Guidelines for Reporting Head and Neck Tumours Compilation and editing of this volume: Dr. Modini Jayawickrama (Consultant Histopathologist) List of contributors Consultant Histopathologists Dr.
More informationThe importance of knowing the lymphatic spread patterns of head and neck cancer for accurate nodal staging on CT: A practical schematic guide
The importance of knowing the lymphatic spread patterns of head and neck cancer for accurate nodal staging on CT: A practical schematic guide Alba L. Reyes Ortiz, MD Elena Capilla, MD. Lina Cruz Hernández,
More informationACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *
ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * CS Tumor Size/Extension Evaluation 24842 12/11/2007: Q:
More informationTemporal fossa Infratemporal fossa Pterygopalatine fossa Terminal branches of external carotid artery Pterygoid venous plexus
Outline of content Temporal fossa Infratemporal fossa Pterygopalatine fossa Terminal branches of external carotid artery Pterygoid venous plexus Boundary Content Communication Mandibular division of trigeminal
More informationManagement of Salivary Gland Malignancies. No Disclosures or Conflicts of Interest. Anatomy 10/4/2013
Management of Salivary Gland Malignancies Daniel G. Deschler, MD Director: Division of Head and Neck Surgery Massachusetts Eye & Ear Infirmary Massachusetts General Hospital Professor Harvard Medical School
More informationHead & Neck Cancer. Two Routes to Cover. Head and Neck Risk Factors cont. Head and Neck Risk Factors. Changes in 2018
Two Routes to Cover Head & Neck Cancer Changes in 2018 1 2 Head and Neck Risk Factors Tobacco (smoking, chewing, dipping snuff) Alcohol Chewing betel nut products (Asia & So Pacific) Men > women Blacks
More informationProtocol for the Examination of Specimens From Patients With Cancers of the Pharynx
Protocol for the Examination of Specimens From Patients With Cancers of the Pharynx Version: Protocol Posting Date: June 2017 Includes ptnm requirements from the 8 th Edition, AJCC Staging Manual For accreditation
More informationCANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I Changes and Clarifications 16 th Edition April 15, 2016 Quick Look- Updates to Volume
More informationCS Evaluation Fields. Outline of Presentation. Purpose of Evaluation Field. CSv2 Title of Presentation Jan 2011 Lecture Version: 1.
CS Evaluation Fields Education and Training Team Collaborative Stage Data Collection System Version 02.03.02 (Effective date: 1/1/2011) Outline of Presentation Purpose AJCC TNM Classification Eval data
More informationCase Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
More informationAnterior triangle of neck
Anterior triangle of neck Dept. of Anatomy Zhou Hong Ying Outline boundary and subdivisions of ant. triangle contents of the triangle Muscles: suprahyoid muscles, infrahyoid muscles Nerves: CNⅩ, CNⅪ, CNⅫ,
More informationNeck-2. Dr. Heba Kalbouneh Associate Professor of Anatomy and Histology
Neck-2 ` Dr. Heba Kalbouneh Associate Professor of Anatomy and Histology Triangles of the neck Side of the neck Midline Lower border of mandible Line between angle of mandible and mastoid Superior nuchal
More informationSince the first description of the radical neck dissection by George Crile almost a century
ORIGINAL ARTICLE Neck Dissection Classification Update Revisions Proposed by the American Head and Neck Society and the American Academy of Otolaryngology Head and Neck Surgery K. Thomas Robbins, MD; Garry
More informationSCHOOL OF ANATOMICAL SCIENCES Mock Run Questions. 4 May 2012
SCHOOL OF ANATOMICAL SCIENCES Mock Run Questions 4 May 2012 1. With regard to the muscles of the neck: a. the platysma muscle is supplied by the accessory nerve. b. the stylohyoid muscle is supplied by
More informationVeins of the Face and the Neck
Veins of the Face and the Neck Facial Vein The facial vein is formed at the medial angle of the eye by the union of the supraorbital and supratrochlear veins. connected through the ophthalmic veins with
More informationHead and Neck Case 1 PATIENT HISTORY
Head and Neck Case 1 PATIENT HISTORY Patient History May 7, 2007 Otolaryngology Head & Neck Subjective: Patient was recently seen by a dentist, who noted a roughness in his lower alveolus, and wanted to
More informationNAACCR Hospital Registry Webinar Series
NAACCR Hospital Registry Webinar Series Shannon Vann, CTR Jim Hofferkamp, CTR Webinar Series 1 Abstracting Larynx Cancer Incidence & Treatment Data Estimated new cases and deaths from laryngeal cancer
More informationAnatomy: head and Neck (6 questions) 1. Prevertebral Flexor Musculature (lying in front of the vertebrae) include all, EXCEPT: Longus Colli.
Anatomy: head and Neck (6 questions) 1. Prevertebral Flexor Musculature (lying in front of the vertebrae) include all, EXCEPT: Longus Colli. Rectus Capitis Anterior. Rectus Capitis Lateralis. Rectus Capitis
More informationDr.Ban I.S. head & neck anatomy 2 nd y. جامعة تكريت كلية طب االسنان املرحلة الثانية
جامعة تكريت كلية طب االسنان التشريح مادة املرحلة الثانية أ.م.د. بان امساعيل صديق 6102-6102 1 The Palate The palate forms the roof of the mouth and the floor of the nasal cavity. It is divided into two
More information1/13/2009. Classification:
SUPPURATIONS OF SPACES RELATED TO THE PHARYNX Assistant Professor, Department of Otolaryngology Head & Neck Surgery Faculty of Medicine, Alexandria University Classification: I. Intratonsillar abscess.
More informationQ&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1
Collecting Cancer Data: Prostate NAACCR 2010-2011 Webinar Series May 5, 2011 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview NAACCR 2010-2011 Webinar Series 1
More informationHead & Neck Staging. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging
AJCC 8 th Edition Staging Head & Neck Staging Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving
More informationAJCC 8 th Edition Staging. Head & Neck Staging. Learning Objectives. This webinar is sponsored by. the Centers for Disease Control and Prevention.
AJCC 8 th Edition Staging Head & Neck Staging Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving
More informationKyle L. Ziegler, CTR. California Cancer Registry U.C. Davis Health System
Kyle L. Ziegler, CTR California Cancer Registry U.C. Davis Health System Overview New Data Items Reportability Clarifications New Coding Rules Grade ICD-O-3 Changes Collaborative Stage v0205 2 New Data
More informationACHIEVING EXCELLENCE IN ABSTRACTING: LYMPHOMA
ACHIEVING EXCELLENCE IN ABSTRACTING: LYMPHOMA ACHIEVING EXCELLENCE IN ABSTRACTING LYMPHOMA Recoding Audit Performed in 2009 260 cases audited 17 data items audited per case 4420 possible discrepancies
More informationCatholic University of Louvain, St - Luc University Hospital Head and Neck Oncology Programme. Anatomopathology. Pathology 1 Sept.
Anatomopathology Pathology 1 Anatomopathology Biopsies Frozen section Surgical specimen Peculiarities for various tumor site References Pathology 2 Biopsies Minimum data, which should be given by the pathologist
More informationBisection of Head & Nasal Cavity 頭部對切以及鼻腔. 解剖學科馮琮涵副教授 分機
Bisection of Head & Nasal Cavity 頭部對切以及鼻腔 解剖學科馮琮涵副教授 分機 3250 E-mail: thfong@tmu.edu.tw Outline: The structure of nose The concha and meatus in nasal cavity The openings of paranasal sinuses Canals, foramens
More informationProtocol for the Examination of Specimens From Patients With Carcinomas of the Pharynx
Protocol for the Examination of Specimens From Patients With Carcinomas of the Pharynx Protocol applies to all invasive carcinomas of the pharynx (oropharynx, nasopharynx, hypopharynx) including the base
More information4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines
SEER EOD and Summary Stage KCR 2018 SPRING TRAINING Overview What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets SEER Summary Stage 2018 Site Specific
More informationOral cavity neoplasms imaging staging
Oral cavity neoplasms imaging staging Poster No.: C-1751 Congress: ECR 2010 Type: Educational Exhibit Topic: Head and Neck Authors: L. Oleaga, M. Squarcia, S. Capurro, J. Berenguer, T. Pujol, M. Olondo,
More informationAJCC Cancer Staging Form Supplement
AJCC Cancer Staging Form Supplement AJCC Cancer Staging Manual, Eighth Edition Last updated 05 June 2018 AMERICAN JOINT COMMITTEE ON CANCER Executive Office 633 North Saint Clair Street Chicago, IL 60611
More informationCase Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.
Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This
More informationChapter 2 Staging of Breast Cancer
Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination
More informationLips and labial mucosa
Lips and labial mucosa External portion of the lips: the vermilion border and the skin Vermilion border : the exposed red portion of the lip, covered by mucous membrane, no mucous glands Boundary: the
More information